Source 1primary paper2025MED
Toolkit/CRISPR-Cas13
CRISPR-Cas13
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
This review comprehensively examines the evolution and current landscape of RNA therapeutics, encompassing major classes such as mRNA vaccines, small interfering RNAs (siRNAs), antisense oligonucleotides (ASOs), and emerging RNA editing technologies like CRISPR-Cas13.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.
Mechanisms
rna editingTechniques
Directed EvolutionTarget processes
editingValidation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Lipid nanoparticle formulations and targeted ligand conjugates are technological innovations that have helped overcome historic challenges related to RNA instability, immunogenicity, and delivery.
CRISPR-Cas13 is an emerging RNA editing technology within the RNA therapeutics landscape.
Approval Evidence
1 source1 linked approval claimfirst-pass slug crispr-cas13
This review comprehensively examines the evolution and current landscape of RNA therapeutics, encompassing major classes such as mRNA vaccines, small interfering RNAs (siRNAs), antisense oligonucleotides (ASOs), and emerging RNA editing technologies like CRISPR-Cas13.
Source:
emerging modalitysupports
CRISPR-Cas13 is an emerging RNA editing technology within the RNA therapeutics landscape.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.